The Nordic EMBL Partnership for Molecular Medicine is a joint venture between the European Molecular Biology Laboratory (EMBL) and the Universities of Helsinki/Finland, Oslo/Norway, Umeå/Sweden, and Aarhus/Denmark. The four nodes of the Partnership adhere to the EMBL model for recruitment, research organization, training, and evaluation, and are primarily organized by Group Leader programmes defining research bottom-up. The Partnership provides joint access to research infrastructures, including databases, facilities, and instrumentation, as well as to clinical materials, networks, and training activities. The Nordic countries offer excellent conditions for research, equal opportunities, and quality of life. 

Group Leader positions with attractive start-up packages and EMBL association 
DANDRITE and MIMS seek candidates with promising original research programmes for the position as Group Leaders with an initial 5-year appointment and the opportunity for a 4-year extension following the EMBL model. Group Leader positions include generous start-up packages and affiliation to the EMBL Partnership and activities. 

Danish node -  DANDRITE

The Danish node of the Nordic EMBL Partnership for Molecular Medicine invites applications from excellent candidates that will establish an independent research programme within molecular, cellular, and translational neuroscience. We encourage applications from candidates with programmes that relate to brain development and neurodevelopmental disorders of the nervous system. Group Leaders are expected to introduce novel topics and tools, strengthen synergies of ongoing DANDRITE research, and build a programme at the international level that can also support collaborations of interdisciplinary and translational neuroscience within Danish and international neuroscience.

DANDRITE group leader positions come with an attractive start-up package of EUR 1.6M, access to state-of-the-art facilities and infrastructure, affiliation as a DANDRITE-AIAS fellow at the Aarhus Institute for Advanced Studies, and ample opportunities to engage with a wide and inspiring international research community in interdisciplinary neuroscience. Clinical research units are available at the top-ranked Aarhus University Hospital, and biotech support structures are available and start-up communities are growing.

The new Group Leaders will receive mentoring from both local and international capacities and will have extensive administrative support.

DANDRITE performs basic and translational research in neuroscience and brain disorders and was established at Aarhus University in 2013 with financial support from the Lundbeck Foundation. We aim at unravelling the fundamental mechanisms that explain cellular communication and computation networks in brain circuitries, and how these are affected in neurodevelopment and neurological and psychiatric disorders.

We expect to recruit one or two new group leaders via this call.  

Read further and apply following this link: https://www.au.dk/om/stillinger/job/dandrite-and-the-nordic-embl-partnership-for-molecular-medicine-invite-candidates-for-the-position-as-group-leader-in-neuroscience
Deadline: July 31^st 2023, 23:59 CET
Contact information: Prof Poul Nissen, Director, phone: +45 2899 2295, pn@mbg.au.dk

Swedish node - MIMS - The Laboratory for Molecular Infection Medicine Sweden 
The Swedish node of the Nordic EMBL Partnership for Molecular Medicine now invites applications from outstanding candidates within molecular infection medicine. MIMS performs basic and translational research in molecular infection medicine and was established at Umeå University in 2007. MIMS is the home of the CRISP/Cas9 discovery, a technology that eventually led to the Nobel Prize in Chemistry in 2020. Major achievements in infection research cover the full range of viral, bacterial and eukaryotic pathogens.  

MIMS offers an exceptional environment for research into bacterial pathogenesis and parasite cell biology. A vibrant community of virologists is associated with the local university hospital. Researchers with an interest in the structural basis of infection will find an outstanding and highly accessible facility for cryo-electron microscopy. Group Leaders are expected to introduce novel topics and tools, to strengthen synergies of ongoing MIMS research, and to build a programme at the international level that can also support interdisciplinary and translational collaborations. 

MIMS Group Leader positions come with an attractive start-up package, access to state-of-the-art facilities and infrastructure and ample opportunities to engage with a wide and inspiring international research community. Clinical research units are available at the University Hospital of Umeå and the vibrant life science activities in Northern Sweden includes growing research and startup activities. The new Group Leader receives mentoring from both local and international capacities. 

Read further and apply via Umeå University´s e-recruitment system for the MIMS Group Leader position: https://umu.varbi.com/en/what:job/jobID:620573/  
Deadline: July 31st 2023, 23:59 CEST 
Contact information: Prof. Oliver Billker, Director, phone: +46 90 785 6778, oliver.billker@umu.se